Evidence map›Paper›PMID 34329865›Full record

ArticleComputers in biology and medicine2021

Classification of SARS-CoV-2 and non-SARS-CoV-2 using machine learning algorithms.

Om Prakash Singh, Marta Vallejo, Ismail M El-Badawy, Ali Aysha, Jagannathan Madhanagopal, Ahmad Athif Mohd Faudzi

Abstract read
In one paragraph

Article in Computers in biology and medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Om Prakash SinghSchool of Chemistry, University of Edinburgh, Edinburgh, UK. Electronic address: bioom85@yahoo.com.
Marta VallejoSchool of Engineering & Physical Sciences, Heriot-Watt University, Edinburgh, UK.
Ismail M El-BadawyElectronics and Communications Engineering Department, Arab Academy for Science and Technology, Cairo, Egypt.
Ali AyshaSchool of Chemistry, University of Edinburgh, Edinburgh, UK.
Jagannathan MadhanagopalSchool of Physiotherapy, Faculty of Allied Health Professional, AIMST University, Semeling Campus, Bedong, Kedah, Malaysia.
Ahmad Athif Mohd FaudziSchool of Electrical Engineering, Universiti Teknologi Malaysia, Johor, Malaysia. Electronic address: athif@utm.my.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Due to the continued evolution of the SARS-CoV-2 pandemic, researchers worldwide are working to mitigate, suppress its spread, and better understand it by deploying digital signal processing (DSP) and machine learning approaches. This study presents an alignment-free approach to classify the SARS-CoV-2 using complementary DNA, which is DNA synthesized from the single-stranded RNA virus. Herein, a total of 1582 samples, with different lengths of genome sequences from different regions, were collected from various data sources and divided into a SARS-CoV-2 and a non-SARS-CoV-2 group. We extracted eight biomarkers based on three-base periodicity, using DSP techniques, and ranked those based on a filter-based feature selection. The ranked biomarkers were fed into k-nearest neighbor, support vector machines, decision trees, and random forest classifiers for the classification of SARS-CoV-2 from other coronaviruses. The training dataset was used to test the performance of the classifiers based on accuracy and F-measure via 10-fold cross-validation. Kappa-scores were estimated to check the influence of unbalanced data. Further, 10 × 10 cross-validation paired t-test was utilized to test the best model with unseen data. Random forest was elected as the best model, differentiating the SARS-CoV-2 coronavirus from other coronaviruses and a control a group with an accuracy of 97.4 %, sensitivity of 96.2 %, and specificity of 98.2 %, when tested with unseen samples. Moreover, the proposed algorithm was computationally efficient, taking only 0.31 s to compute the genome biomarkers, outperforming previous studies.

Indexed as

COVID-19SARS-CoV-2AlgorithmsHumansMachine LearningPandemicsBiomarkerCOVID-19Machine learningSignal processing

Identifiers

PMID34329865
PMCPMC8294595

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.